Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionTrustcore Financial Services, Llc
Latest Disclosed Ownership208,806 shares
Latest Disclosed Value $ 4,240,850
Trustcore Financial Services, Llc ownership in CORT / Corcept Therapeutics Incorporated

On February 13, 2023 - Trustcore Financial Services, Llc filed a 13F-HR form disclosing ownership of 208,806 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $4,240,850 USD as of December 31, 2022. The entity filed a previous 13F-HR on November 3, 2022 disclosing 208,806 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $15,163,492 USD.

Trustcore Financial Services, Llc has a history of taking positions in derivatives of the underlying security (CORT) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CORT / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 208,806 0 0.00 4,241 -20.81 0.0004
2022-11-03 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 208,806 0 0.00 5,354 7.83 0.5083
2022-07-26 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 208,806 0 0.00 4,965 5.59 0.4615
2022-05-09 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 208,806 570 0.27 4,702 14.04 0.4060
2022-02-09 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 208,236 -8,459 -3.90 4,123 -3.33 0.4657
2021-11-08 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 216,695 130,000 149.95 4,265 123.65 0.4192
2021-08-02 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 86,695 0 0.00 1,907 -7.52 0.2005
2021-04-30 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 86,695 -20,000 -18.75 2,062 -26.12 0.2389
2021-02-04 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 106,695 45,765 75.11 2,791 163.30 0.3563
2020-11-02 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 60,930 40,160 193.36 1,060 203.72 0.1610
2020-07-29 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 20,770 -63,198 -75.26 349 -65.03 0.0604
2020-05-07 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 83,968 0 0.00 998 -1.77 0.2248
2020-01-30 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 83,968 63,900 318.42 1,016 257.75 0.1922
2019-10-30 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 20,068 -29,500 -59.51 284 -48.64 0.0609
2019-07-25 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 49,568 0 0.00 553 -4.98 0.1237
2019-05-07 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 49,568 49,568 582 0.1609
2019-02-05 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -49,568 -100.00 0 -100.00
2018-11-09 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 49,568 49,085 10,162.53 695 8,587.50 0.2176
2018-07-30 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 483 0 0.00 8 0.00 0.0028
2018-05-04 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 483 483 8 0.0030
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-07 2020-03-31 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-01-30 2019-12-31 13F CORCEPT THERAPEUTICS COM Put 48,700 589 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.